Clinical Trial

Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.
Trial Details
NCT Number NCT06926959
Lead Sponsor Sun Yat-sen University
Collaborators: First Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University, Affiliated Hospital of Guangdong Medical University, Second Affiliated Hospital of Shantou University Medical College, Eighth Affiliated Hospital, Sun Yat-sen University, Zhongshan People's Hospital, Guangdong, China, Jieyang People's Hospital
Conditions Tricuspid Regurgitation
Enrollment 3,000 participants
Start Date 2016-06-15
Primary Completion 2030-06-15 (estimated)
Study Completion 2030-06-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-15